MESOTHELIOMA, MALIGNANT
Clinical trials for MESOTHELIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR t therapy targets three tough cancers in first human trial
Disease control Recruiting nowThis early-stage study tests a new treatment called SynKIR-110 for people with advanced ovarian cancer, bile duct cancer, or mesothelioma that has come back. The therapy uses a patient's own immune cells, modified to better attack cancer cells that have a protein called mesotheli…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Smart CAR t cells aim to outsmart solid tumors in new trial
Disease control Recruiting nowThis study tests a new type of CAR T cell therapy for adults with advanced solid tumors, including colorectal, pancreatic, lung, ovarian, and mesothelioma cancers. The therapy uses a patient's own immune cells, modified to recognize and attack cancer cells that have lost a specif…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE1, PHASE2 • Sponsor: A2 Biotherapeutics Inc. • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New pill targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis early-phase study tests a new oral drug, SW-682, in adults with advanced solid tumors that have not responded to standard treatments. The study focuses on cancers with specific genetic changes in the Hippo pathway. The goal is to find a safe dose and see if the drug can shri…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE1 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Can surgery ease suffering in incurable lung cancer?
Symptom relief Recruiting nowThis study looks at whether a limited surgery to remove part of the lung lining (partial pleurectomy) can reduce symptoms and improve quality of life for people with advanced pleural mesothelioma that cannot be fully removed. About 30 participants will have the surgery and report…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: NA • Sponsor: University of Chicago • Aim: Symptom relief
Last updated May 19, 2026 11:46 UTC
-
Could your cells hold the key to a new cancer therapy?
Knowledge-focused Recruiting nowThis study is gathering tumor tissue and blood cells from 200 adults with advanced solid tumors like colorectal, lung, or pancreatic cancer. The goal is to learn how often certain genetic changes occur and to store participants' own immune cells for possible future use in making …
Matched conditions: MESOTHELIOMA, MALIGNANT
Sponsor: A2 Biotherapeutics Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 14:02 UTC